Cargando…

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave

This study investigated the clinical management of non small cell lung cancer (NSCLC) patients during the first wave of coronavirus disease 2019 (COVID-19) outbreak in Italy. A 29-questions survey was sent to 95 Italian thoracic oncologists, with 77 % of them declaring significant changes in the out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertaglia, Valentina, Reale, Maria Lucia, Bironzo, Paolo, Palesandro, Erica, Mariniello, Annapaola, Leone, Gianmarco, Tabbò, Fabrizio, Bungaro, Maristella, Audisio, Marco, Rapetti, Simonetta, Di Stefano, Rosario Francesco, Carnio, Simona, Artusio, Elisa, Capelletto, Enrica, Sperone, Paola, Passiglia, Francesco, Novello, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691849/ https://www.ncbi.nlm.nih.gov/pubmed/33341505 http://dx.doi.org/10.1016/j.critrevonc.2020.103189

Ejemplares similares

SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit
por: Reale, Maria Lucia, et al.
Publicado: (2020)

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
por: Mariniello, Annapaola, et al.
Publicado: (2022)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
por: Leone, Gianmarco, et al.
Publicado: (2020)

Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center
por: Bungaro, Maristella, et al.
Publicado: (2021)

MA12.07 Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center
por: Bungaro, M., et al.
Publicado: (2021)

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations
por: Bironzo, Paolo, et al.
Publicado: (2021)

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients—An Italian Single-Center Experience
por: Persano, Irene, et al.
Publicado: (2023)

Local for advanced, is this a paradox?
por: Bungaro, Maristella, et al.
Publicado: (2021)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience
por: Capelletto, Enrica, et al.
Publicado: (2020)

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
por: Bungaro, Maristella, et al.
Publicado: (2022)

Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review
por: Garbo, Edoardo, et al.
Publicado: (2023)

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
por: Passiglia, Francesco, et al.
Publicado: (2022)

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes
por: Mogavero, Andrea, et al.
Publicado: (2023)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Fatigue in lung cancer patients: symptom burden and management of challenges
por: Carnio, Simona, et al.
Publicado: (2016)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
por: Passiglia, Francesco, et al.
Publicado: (2023)

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2019)

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020
por: Paratore, C., et al.
Publicado: (2022)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways
por: Bungaro, Maristella, et al.
Publicado: (2020)

How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers?
por: Cani, Massimiliano, et al.
Publicado: (2023)

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
por: Dumoulin, Daphne W., et al.
Publicado: (2023)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
por: Passiglia, Francesco, et al.
Publicado: (2021)

New emerging targets in cancer immunotherapy: the role of VISTA
por: Tagliamento, Marco, et al.
Publicado: (2020)

Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now?
por: Mecca, Caterina, et al.
Publicado: (2019)

Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer
por: Ciani, Oriana, et al.
Publicado: (2019)

Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021
por: Zhang, Kaiping, et al.
Publicado: (2022)

Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies
por: Cani, Massimiliano, et al.
Publicado: (2023)

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach
por: Bruni, Alessio, et al.
Publicado: (2019)

Future perspectives from lung cancer pre-clinical models: new treatments are coming?
por: Bersani, Francesca, et al.
Publicado: (2020)

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
por: Caminiti, Caterina, et al.
Publicado: (2022)

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020)

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1(+) Chemoresistant Lung Cancer Cells
por: Rotolo, Ramona, et al.
Publicado: (2023)

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib
por: Malapelle, Umberto, et al.
Publicado: (2022)

An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
por: Bironzo, Paolo, et al.
Publicado: (2023)

Diet and Plastic Ingestion in the Blackmouth Catshark Galeus melastomus, Rafinesque 1810, in Italian Waters
por: Zicarelli, Giorgia, et al.
Publicado: (2023)

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
por: Liberini, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_emtqflqtvl9911aj29hsb6vctl